Search Results - "Muhammad Mustafa Memon"

Refine Results
  1. 1

    Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: A systematic review and meta-analysis by Usman, Muhammad Shariq, Siddiqi, Tariq Jamal, Memon, Muhammad Mustafa, Khan, Muhammad Shahzeb, Rawasia, Wasiq Faraz, Talha Ayub, Muhammad, Sreenivasan, Jayakumar, Golzar, Yasmeen

    Published in European journal of preventive cardiology (01-03-2018)
    “…Background The risks and benefits of sodium-glucose co-transporter 2 (SGLT2) inhibitors on cardiovascular outcomes have not been well established. We pooled…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Knowledge Attitude and Practices among Medical Students Regarding Acne by Deepa Mohan Lal, Maria Mansoor, Emaan Amin, Muhammad Mustafa Memon, Maaz S. Khan, Humaira Talat, Reema Mirza, Zarnaz Wahid

    “…OBJECTIVE: To investigate knowledge, attitudes, practices, and quality of life of patients with acne. METHODOLOGY: This observational cross-sectional study was…”
    Get full text
    Journal Article
  5. 5

    Meta-Analysis Evaluating Risk of Hyperkalemia Stratified by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors by Ahmed, Aymen, Ahmed, Warda, Arshad, Muhammad Sameer, Suri, Azeema, Amin, Emaan, Shahid, Izza, Memon, Muhammad Mustafa

    Published in Cardiovascular drugs and therapy (01-10-2024)
    “…Background Both mineralocorticoid receptor antagonists (MRAs) and sodium-glucose co-transporter type 2 inhibitors (SGLT2is) have demonstrated beneficial…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis by Khan, Muhammad Shahzeb, Memon, Muhammad Mustafa, Amin, Emaan, Yamani, Naser, Khan, Safi U, Figueredo, Vincent M, Deo, Salil, Rich, Jonathan D, Benza, Raymond L, Krasuski, Richard A

    Published in Chest (01-07-2019)
    “…Despite the use and purported benefits of balloon atrial septostomy (BAS), its safety, efficacy, and therapeutic role in the setting of advanced pulmonary…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Outcomes Associated with Obesity in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis by Khan, Muhammad Shahzeb, Yuzefpolskaya, Melana, Memon, Muhammad Mustafa, Usman, Muhammad Shariq, Yamani, Naser, Garan, A. Reshad, Demmer, Ryan T., Colombo, Paolo C.

    Published in ASAIO journal (1992) (01-04-2020)
    “…Current data suggest that obesity does not impact survival, but may predispose patients to a higher rate of adverse events during left ventricular assist…”
    Get full text
    Journal Article
  18. 18

    Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension by Khan, Muhammad Shahzeb, Memon, Muhammad Mustafa, Amin, Emaan, Yamani, Naser, Khan, Safi U., Figueredo, Vincent M., Deo, Salil, Rich, Jonathan D., Benza, Raymond L., Krasuski, Richard A.

    Published in Chest (01-07-2019)
    “…Despite the use and purported benefits of balloon atrial septostomy (BAS), its safety, efficacy, and therapeutic role in the setting of advanced pulmonary…”
    Get full text
    Journal Article
  19. 19
  20. 20